Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 181 articles:
HTML format



Single Articles


    April 2008
  1. LAURIELLO J , Lambert T, Andersen S, Lin D, et al
    An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia.
    J Clin Psychiatry. 2008;:e1-e10.
    PubMed     Related articles    Abstract available


  2. BLONDE L , Kan HJ, Gutterman EM, L'italien GJ, et al
    Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available


    March 2008
  3. CHANG JS , Ahn YM, Park HJ, Lee KY, et al
    Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    J Clin Psychiatry. 2008;:e1-e12.
    PubMed     Related articles    Abstract available


  4. GLICK ID , Siris SG, Davis JM
    Treating schizophrenia with comorbid depressive or demoralization symptoms.
    J Clin Psychiatry. 2008;69:501.
    PubMed     Related articles   


  5. VILLERO S , Fraguas D
    Gender imbalance in clinical trials in schizophrenia.
    J Clin Psychiatry. 2008;69:498-9.
    PubMed     Related articles   



  6. Clinical insights into pharmacogenetics and schizophrenia, part 1.
    J Clin Psychiatry. 2008;69:487-94.
    PubMed     Related articles   


  7. TARIOT PN
    Psychosis and agitation in dementia: should general psychiatrists care?
    J Clin Psychiatry. 2008;69:339-40.
    PubMed     Related articles   


    February 2008
  8. LEE SJ , Choi EJ, Kwon JS
    A Naturalistic Multicenter Trial of a 12-Week Weight Management Program for Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available


  9. WILCOCK GK , Ballard CG, Cooper JA, Loft H, et al
    Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available


  10. KISHIMOTO T , Watanabe K, Shimada N, Makita K, et al
    Antipsychotic-Induced Hyperprolactinemia Inhibits the Hypothalamo-Pituitary-Gonadal Axis and Reduces Bone Mineral Density in Male Patients With Schizophrenia.
    J Clin Psychiatry. 2008;:e1-e7.
    PubMed     Related articles    Abstract available


  11. MATHIAS S , Lubman DI, Hides L
    Substance-Induced Psychosis: A Diagnostic Conundrum.
    J Clin Psychiatry. 2008;:e1-e10.
    PubMed     Related articles    Abstract available


  12. VAN WINKEL R , De Hert M, Wampers M, Van Eyck D, et al
    Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available


  13. PREDA A
    Shared decision making in schizophrenia treatment.
    J Clin Psychiatry. 2008;69:326.
    PubMed     Related articles   


  14. ROTH BL
    High-dose olanzapine for treatment-resistant schizophrenia.
    J Clin Psychiatry. 2008;69:176-7.
    PubMed     Related articles   


  15. LEO R , Razzini C, Di Lorenzo G, Bianchi F, et al
    Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
    J Clin Psychiatry. 2008;69:327-8.
    PubMed     Related articles   


  16. TAYLOR M , Shajahan P, Lawrie SM
    Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
    J Clin Psychiatry. 2008;69:240-5.
    PubMed     Related articles    Abstract available


  17. MORRATO EH , Newcomer JW, Allen RR, Valuck RJ, et al
    Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.
    J Clin Psychiatry. 2008;69:316-22.
    PubMed     Related articles    Abstract available


    January 2008
  18. MELTZER HY , Bobo WV, Roy A, Jayathilake K, et al
    A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia.
    J Clin Psychiatry. 2008;:e1-e12.
    PubMed     Related articles    Abstract available


  19. MARTINEZ-ARAN A , Torrent C, Tabares-Seisdedos R, Salamero M, et al
    Neurocognitive Impairment in Bipolar Patients With and Without History of Psychosis.
    J Clin Psychiatry. 2008;:e1-e7.
    PubMed     Related articles    Abstract available


  20. GAO K , Ganocy SJ, Gajwani P, Muzina DJ, et al
    A Review of Sensitivity and Tolerability of Antipsychotics in Patients With Bipolar Disorder or Schizophrenia: Focus on Somnolence.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available


  21. MITSONIS CI , Mitropoulos PA, Dimopoulos NP, Kararizou EG, et al
    Vardenafil in the Treatment of Erectile Dysfunction in Outpatients With Chronic Schizophrenia: A Flexible-Dose, Open-Label Study.
    J Clin Psychiatry. 2008;:e1-e7.
    PubMed     Related articles    Abstract available


  22. MURPHY BP
    Inconclusive evidence for the efficacy of olanzapine in the treatment of negative symptoms in schizophrenia.
    J Clin Psychiatry. 2008;69:164.
    PubMed     Related articles   


  23. SILVER H
    Selective serotonin reuptake inhibitor add-on therapy for the negative symptoms of schizophrenia.
    J Clin Psychiatry. 2008;69:163-4.
    PubMed     Related articles   


  24. PERKINS DO , Gu H, Weiden PJ, McEvoy JP, et al
    Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
    J Clin Psychiatry. 2008;69:106-13.
    PubMed     Related articles    Abstract available


  25. HUDSON TJ , Owen RR, Thrush CR, Armitage TL, et al
    Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
    J Clin Psychiatry. 2008;69:74-80.
    PubMed     Related articles    Abstract available


  26. LAW MR , Soumerai SB, Ross-Degnan D, Adams AS, et al
    A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia.
    J Clin Psychiatry. 2008;69:47-53.
    PubMed     Related articles    Abstract available


  27. LIN YC , Chen HZ, Chang TJ, Lane HY, et al
    Hypokalemia following rapid titration of quetiapine treatment.
    J Clin Psychiatry. 2008;69:165-6.
    PubMed     Related articles   


  28. STROM BL , Faich GA, Reynolds RF, Eng SM, et al
    The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
    J Clin Psychiatry. 2008;69:114-21.
    PubMed     Related articles    Abstract available


  29. MAMO DC , Uchida H, Vitcu I, Barsoum P, et al
    Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study.
    J Clin Psychiatry. 2008;69:81-6.
    PubMed     Related articles    Abstract available


  30. MANN JJ , Ellis SP, Waternaux CM, Liu X, et al
    Classification trees distinguish suicide attempters in major psychiatric disorders: a model of clinical decision making.
    J Clin Psychiatry. 2008;69:23-31.
    PubMed     Related articles    Abstract available


    December 2007
  31. PERKINS DO , Gu H, Weiden PJ, McEvoy JP, et al
    Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study.
    J Clin Psychiatry. 2007;:e1-e8.
    PubMed     Related articles    Abstract available


  32. RAO NP , Venkatasubramanian G, Gangadhar BN
    Treatment of cognitive deficits in schizophrenia with atomoxetine: a case report.
    J Clin Psychiatry. 2007;68:1988-9.
    PubMed     Related articles   


  33. COMPTON MT , Whicker NE, Hochman KM
    Alcohol and cannabis use in Urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms.
    J Clin Psychiatry. 2007;68:1939-45.
    PubMed     Related articles    Abstract available


  34. MILLER DEL D , Eudicone JM, Pikalov A, Kim E, et al
    Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    J Clin Psychiatry. 2007;68:1901-6.
    PubMed     Related articles    Abstract available


  35. BERGER GE , Proffitt TM, McConchie M, Yuen H, et al
    Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
    J Clin Psychiatry. 2007;68:1867-75.
    PubMed     Related articles    Abstract available


  36. MEI BAI Y , Chen JY, Yang WS, Chi YC, et al
    Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.
    J Clin Psychiatry. 2007;68:1834-9.
    PubMed     Related articles    Abstract available


  37. KHAN A , Schwartz K, Stern C, Redding N, et al
    Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials.
    J Clin Psychiatry. 2007;68:1828-33.
    PubMed     Related articles    Abstract available


  38. CITROME L
    Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.
    J Clin Psychiatry. 2007;68:1876-85.
    PubMed     Related articles    Abstract available


    November 2007
  39. SADDICHHA S , Manjunatha N, Ameen S, Akhtar S, et al
    Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
    J Clin Psychiatry. 2007;68:1793-8.
    PubMed     Related articles    Abstract available


  40. GAEBEL W , Riesbeck M, Wolwer W, Klimke A, et al
    Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German research network on schizophrenia.
    J Clin Psychiatry. 2007;68:1763-74.
    PubMed     Related articles    Abstract available


  41. MOORE TA , Buchanan RW, Buckley PF, Chiles JA, et al
    The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update.
    J Clin Psychiatry. 2007;68:1751-62.
    PubMed     Related articles    Abstract available


  42. PEREZ-IGLESIAS R , Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, et al
    A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    J Clin Psychiatry. 2007;68:1733-40.
    PubMed     Related articles    Abstract available


  43. BUSHE CJ , Leonard BE
    Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.
    J Clin Psychiatry. 2007;68:1682-90.
    PubMed     Related articles    Abstract available


  44. MUNK LAURSEN T , Munk-Olsen T, Nordentoft M, Bo Mortensen P, et al
    A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a danish population-based cohort.
    J Clin Psychiatry. 2007;68:1673-81.
    PubMed     Related articles    Abstract available


  45. HETTEMA JM , Ross DE
    A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
    J Clin Psychiatry. 2007;68:1814-5.
    PubMed     Related articles   


  46. ROSENHECK RA
    Aripiprazole and perphenazine: no difference.
    J Clin Psychiatry. 2007;68:1812-3.
    PubMed     Related articles   


  47. KANE JM
    Teaching and practicing psychopharmacology.
    J Clin Psychiatry. 2007;68:1807-8.
    PubMed     Related articles   



  48. The roadmap for antipsychotic psychopharmacology: an overview.
    J Clin Psychiatry. 2007;68:1799-806.
    PubMed     Related articles   


  49. LERNER V , Miodownik C, Kaptsan A, Bersudsky Y, et al
    Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
    J Clin Psychiatry. 2007;68:1648-54.
    PubMed     Related articles    Abstract available


    October 2007
  50. LIN CH , Chou LS, Lin CH, Hsu CY, et al
    Early Prediction of Clinical Response in Schizophrenia Patients Receiving the Atypical Antipsychotic Zotepine.
    J Clin Psychiatry. 2007;68:1522-1527.
    PubMed     Related articles    Abstract available


  51. L'ITALIEN GJ , Casey DE, Kan HJ, Carson WH, et al
    Comparison of Metabolic Syndrome Incidence Among Schizophrenia Patients Treated With Aripiprazole Versus Olanzapine or Placebo.
    J Clin Psychiatry. 2007;68:1510-1516.
    PubMed     Related articles    Abstract available


  52. POTKIN SG , Cohen M, Panagides J
    Efficacy and Tolerability of Asenapine in Acute Schizophrenia: A Placebo- and Risperidone-Controlled Trial.
    J Clin Psychiatry. 2007;68:1492-1500.
    PubMed     Related articles    Abstract available


  53. ROSA MO , Gattaz WF, Rosa MA, Rumi DO, et al
    Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine.
    J Clin Psychiatry. 2007;68:1528-32.
    PubMed     Related articles    Abstract available


  54. HAUPT DW , Kane JM
    Metabolic risks and effects of atypical antipsychotic treatment.
    J Clin Psychiatry. 2007;68:e24.
    PubMed     Related articles    Abstract available


    September 2007
  55. KAPUSTA ND , Mossaheb N, Barnas C, Fischer P, et al
    Aripiprazole-Induced Psychosis: A Case Report of Reexposure by Stepwise Up-Titration.
    J Clin Psychiatry. 2007;68:1445-1446.
    PubMed     Related articles    Abstract available


  56. SIM K , Chan YH, Chong SA, Siris SG, et al
    A 24-Month Prospective Outcome Study of First-Episode Schizophrenia and Schizoaffective Disorder Within an Early Psychosis Intervention Program.
    J Clin Psychiatry. 2007;68:1368-1376.
    PubMed     Related articles    Abstract available


  57. XU MQ , Xing QH, Zheng YL, Li S, et al
    Association of AKT1 Gene Polymorphisms With Risk of Schizophrenia and With Response to Antipsychotics in the Chinese Population.
    J Clin Psychiatry. 2007;68:1358-1367.
    PubMed     Related articles    Abstract available


  58. LOEBEL AD , Khanna S, Rajadhyaksha S, Siu CO, et al
    Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study.
    J Clin Psychiatry. 2007;68:1333-1338.
    PubMed     Related articles    Abstract available


  59. HARVEY PD
    Managing Cognitive Deficits and Functioning in Patients With Schizophrenia.
    J Clin Psychiatry. 2007;68:e21.
    PubMed     Related articles    Abstract available


    August 2007
  60. COHEN D
    Applicability of the Oral Glucose Tolerance Test in Assessing Prevalence and Incidence of Diabetes Mellitus in Schizophrenia.
    J Clin Psychiatry. 2007;68:1307-1308.
    PubMed     Related articles    Abstract available


  61. DUNAYEVICH E , Ascher-Svanum H, Zhao F, Jacobson JG, et al
    Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder.
    J Clin Psychiatry. 2007;68:1163-1171.
    PubMed     Related articles    Abstract available


  62. GAILLARD R , Hemras A, Habert MO, Baup N, et al
    Cognitive facilitation and behavioral disinhibition with benzodiazepine: a case report.
    J Clin Psychiatry. 2007;68:1305-6.
    PubMed     Related articles   


  63. BAI YM , Ting Chen T, Chen JY, Chang WH, et al
    Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study.
    J Clin Psychiatry. 2007;68:1218-25.
    PubMed     Related articles    Abstract available


    July 2007
  64. AICHHORN W , Stelzig-Schoeler R, Geretsegger C, Stuppaeck C, et al
    Bright light therapy for negative symptoms in schizophrenia: a pilot study.
    J Clin Psychiatry. 2007;68:1146.
    PubMed     Related articles   


  65. SUVISAARI JM , Saarni SI, Perala J, Suvisaari JV, et al
    Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.
    J Clin Psychiatry. 2007;68:1045-55.
    PubMed     Related articles    Abstract available


  66. LIBOV I , Miodownik C, Bersudsky Y, Dwolatzky T, et al
    Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    J Clin Psychiatry. 2007;68:1031-7.
    PubMed     Related articles    Abstract available


  67. HAMANN J , Cohen R, Leucht S, Busch R, et al
    Shared decision making and long-term outcome in schizophrenia treatment.
    J Clin Psychiatry. 2007;68:992-7.
    PubMed     Related articles    Abstract available


  68. KORTNER K , Neuhaus AH, Schurer F, Dettling M, et al
    Eosinophilia indicating subclinical clozapine-induced pericarditis.
    J Clin Psychiatry. 2007;68:1147-8.
    PubMed     Related articles   


  69. ATKINSON JM , Douglas-Hall P, Fischetti C, Sparshatt A, et al
    Outcome following clozapine discontinuation: a retrospective analysis.
    J Clin Psychiatry. 2007;68:1027-30.
    PubMed     Related articles    Abstract available


  70. GOFF DC , Newcomer JW
    Integrating general health care in private community psychiatry practice.
    J Clin Psychiatry. 2007;68:e19.
    PubMed     Related articles    Abstract available


    June 2007
  71. SALZMAN C , Rosenberg J, Feldman JJ
    Schizophrenia symptoms remain stable during decreases from 2 antipsychotics to aripiprazole.
    J Clin Psychiatry. 2007;68:970.
    PubMed     Related articles   


  72. BIRKENAES AB , Opjordsmoen S, Brunborg C, Engh JA, et al
    The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study.
    J Clin Psychiatry. 2007;68:917-23.
    PubMed     Related articles    Abstract available


  73. LAURSEN TM , Munk-Olsen T, Nordentoft M, Mortensen PB, et al
    Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.
    J Clin Psychiatry. 2007;68:899-907.
    PubMed     Related articles    Abstract available


  74. KAPTSAN A , Odessky A, Osher Y, Levine J, et al
    Lack of efficacy of 5 grams daily of creatine in schizophrenia: a randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry. 2007;68:881-4.
    PubMed     Related articles    Abstract available


  75. BAUML J , Pitschel-Walz G, Volz A, Engel RR, et al
    Psychoeducation in schizophrenia: 7-year follow-up concerning rehospitalization and days in hospital in the Munich Psychosis Information Project Study.
    J Clin Psychiatry. 2007;68:854-61.
    PubMed     Related articles    Abstract available


  76. KAHN RS , Schulz SC, Palazov VD, Reyes EB, et al
    Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
    J Clin Psychiatry. 2007;68:832-42.
    PubMed     Related articles    Abstract available


  77. COOPER D , Moisan J, Gregoire JP
    Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.
    J Clin Psychiatry. 2007;68:818-25.
    PubMed     Related articles    Abstract available


  78. GANGULI R , Vreeland B, Newcomer JW
    Monitoring and managing weight gain in the mentally ill.
    J Clin Psychiatry. 2007;68:e14.
    PubMed     Related articles   


    May 2007
  79. ARRANZ B , San L
    What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?
    J Clin Psychiatry. 2007;68:800-1.
    PubMed     Related articles   


  80. AHUJA N , Lloyd AJ
    Aripiprazole and worsening of psychosis: a case report.
    J Clin Psychiatry. 2007;68:805-6.
    PubMed     Related articles   


  81. KARAGIANIS J , Hoffmann VP, Stauffer VL, Treuer T, et al
    What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?
    J Clin Psychiatry. 2007;68:799-800.
    PubMed     Related articles   


  82. WADE D , Harrigan S, McGorry PD, Burgess PM, et al
    Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis.
    J Clin Psychiatry. 2007;68:767-74.
    PubMed     Related articles    Abstract available


  83. ZHANG XY , Tan YL, Zhou DF, Cao LY, et al
    Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
    J Clin Psychiatry. 2007;68:754-60.
    PubMed     Related articles    Abstract available


  84. GRANHOLM E , McQuaid JR, McClure FS, Link PC, et al
    Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up.
    J Clin Psychiatry. 2007;68:730-7.
    PubMed     Related articles    Abstract available


  85. PIERRE JM , Peloian JH, Wirshing DA, Wirshing WC, et al
    A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    J Clin Psychiatry. 2007;68:705-10.
    PubMed     Related articles    Abstract available


  86. PALMER BW , Dunn LB, Depp CA, Eyler LT, et al
    Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects.
    J Clin Psychiatry. 2007;68:689-96.
    PubMed     Related articles    Abstract available


  87. MARDER SR , West B, Lau GS, Pultz JA, et al
    Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.
    J Clin Psychiatry. 2007;68:662-8.
    PubMed     Related articles    Abstract available


  88. WUNDERINK L , Nienhuis FJ, Sytema S, Slooff CJ, et al
    Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    J Clin Psychiatry. 2007;68:654-61.
    PubMed     Related articles    Abstract available


  89. HENNEKENS CH , Newcomer JW
    Series introduction and cardiovascular disease in patients with schizophrenia.
    J Clin Psychiatry. 2007;68:e12.
    PubMed     Related articles   


  90. HUANG CL , Su KP, Hsu HB, Pariante CM, et al
    A pilot observational crossover study of QTc interval changes associated with switching between olanzapine and risperidone.
    J Clin Psychiatry. 2007;68:803-5.
    PubMed     Related articles   


  91. YAMAMOTO K , Fukuda M, Nogawa A, Takahashi E, et al
    Decreased lipoprotein lipase as a risk factor for atypical neuroleptic-induced hypertriglyceridemia.
    J Clin Psychiatry. 2007;68:802.
    PubMed     Related articles   


  92. WIEDEN PJ , Newcomer JW
    Evidence of switching antipsychotic therapy to improve metabolic disturbances.
    J Clin Psychiatry. 2007;68:e13.
    PubMed     Related articles   


    April 2007
  93. SEPEHRY AA , Potvin S, Elie R, Stip E, et al
    Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis.
    J Clin Psychiatry. 2007;68:604-10.
    PubMed     Related articles    Abstract available


  94. BRECHER M , Leong RW, Stening G, Osterling-Koskinen L, et al
    Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.
    J Clin Psychiatry. 2007;68:597-603.
    PubMed     Related articles    Abstract available


  95. MORKEN G , Grawe RW, Widen JH
    Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.
    J Clin Psychiatry. 2007;68:566-71.
    PubMed     Related articles    Abstract available


  96. CORNBLATT BA , Lencz T, Smith CW, Olsen R, et al
    Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.
    J Clin Psychiatry. 2007;68:546-57.
    PubMed     Related articles    Abstract available


  97. MAHENDRAN R , Liew E, Subramaniam M
    De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study.
    J Clin Psychiatry. 2007;68:542-5.
    PubMed     Related articles    Abstract available


  98. HENDERSON DC , Cagliero E, Copeland PM, Louie PM, et al
    Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
    J Clin Psychiatry. 2007;68:533-41.
    PubMed     Related articles    Abstract available


    March 2007

  99. New developments in the treatment of schizophrenia.
    J Clin Psychiatry. 2007;68:463-78.
    PubMed     Related articles   


  100. ALEMAN A , Sommer IE, Kahn RS
    Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis.
    J Clin Psychiatry. 2007;68:416-21.
    PubMed     Related articles    Abstract available


  101. PAE CU , Kim JJ, Lee CU, Lee SJ, et al
    Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial.
    J Clin Psychiatry. 2007;68:399-405.
    PubMed     Related articles    Abstract available


  102. LINDENMAYER JP , Khan A, Iskander A, Abad MT, et al
    A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    J Clin Psychiatry. 2007;68:368-79.
    PubMed     Related articles    Abstract available


  103. HOWES OD , Wheeler MJ, Pilowsky LS, Landau S, et al
    Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.
    J Clin Psychiatry. 2007;68:361-7.
    PubMed     Related articles    Abstract available


  104. LEUCHT S , Busch R, Kissling W, Kane JM, et al
    Early prediction of antipsychotic nonresponse among patients with schizophrenia.
    J Clin Psychiatry. 2007;68:352-60.
    PubMed     Related articles    Abstract available


  105. CAROFF SN , Walker P, Campbell C, Lorry A, et al
    Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
    J Clin Psychiatry. 2007;68:410-5.
    PubMed     Related articles    Abstract available


  106. SPURLING RD , Lamberti JS, Olsen D, Tu X, et al
    Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review.
    J Clin Psychiatry. 2007;68:406-9.
    PubMed     Related articles    Abstract available


    February 2007
  107. GHARABAWI GM , Bossie CA, Pandina GJ, Kujawa MJ, et al
    A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
    J Clin Psychiatry. 2007;68:333.
    PubMed     Related articles   


  108. CITROME L
    The psychopharmacology of violence with emphasis on schizophrenia, part 2: long-term treatment.
    J Clin Psychiatry. 2007;68:331-2.
    PubMed     Related articles   


  109. SURESH KUMAR PN , Andrade C, Bhakta SG, Singh NM, et al
    Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study.
    J Clin Psychiatry. 2007;68:237-41.
    PubMed     Related articles    Abstract available


  110. KANE JM , Meltzer HY, Carson WH Jr, McQuade RD, et al
    Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
    J Clin Psychiatry. 2007;68:213-23.
    PubMed     Related articles    Abstract available


  111. ROSENHECK RA , Lieberman JA
    Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia.
    J Clin Psychiatry. 2007;68:e05.
    PubMed     Related articles    Abstract available


  112. LIEBERMAN JA
    Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials.
    J Clin Psychiatry. 2007;68:e04.
    PubMed     Related articles    Abstract available


  113. KELLER ASHTON A
    Indexing of reports on aripiprazole augmentation of clozapine.
    J Clin Psychiatry. 2007;68:334-5.
    PubMed     Related articles   


    January 2007
  114. MEYER JM
    Strategies for the Long-Term Treatment of Schizophrenia: Real-World Lessons From the CATIE Trial.
    J Clin Psychiatry. 2007;68 Suppl 1:28-33.
    PubMed     Related articles    Abstract available


  115. WEIDEN PJ
    Discontinuing and Switching Antipsychotic Medications: Understanding the CATIE Schizophrenia Trial.
    J Clin Psychiatry. 2007;68 Suppl 1:12-9.
    PubMed     Related articles    Abstract available


  116. NASRALLAH HA
    The Roles of Efficacy, Safety, and Tolerability in Antipsychotic Effectiveness: Practical Implications of the CATIE Schizophrenia Trial.
    J Clin Psychiatry. 2007;68 Suppl 1:5-11.
    PubMed     Related articles    Abstract available


  117. CITROME L
    The psychopharmacology of violence with emphasis on schizophrenia, part 1: acute treatment.
    J Clin Psychiatry. 2007;68:163-4.
    PubMed     Related articles   


  118. DRAKE RJ , Dunn G, Tarrier N, Bentall RP, et al
    Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England.
    J Clin Psychiatry. 2007;68:81-6.
    PubMed     Related articles    Abstract available


  119. KAROW A , Czekalla J, Dittmann RW, Schacht A, et al
    Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.
    J Clin Psychiatry. 2007;68:75-80.
    PubMed     Related articles    Abstract available


  120. CHAN HY , Lin WW, Lin SK, Hwang TJ, et al
    Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in chinese patients with risperidone as an active control: a randomized trial.
    J Clin Psychiatry. 2007;68:29-36.
    PubMed     Related articles    Abstract available


  121. ROBERT BRASHEAR H , Spivey JM
    Galantamine and QTc prolongation.
    J Clin Psychiatry. 2007;68:169.
    PubMed     Related articles   



  122. Practical applications of recent antipsychotic effectiveness data.
    J Clin Psychiatry. 2007;68:151-62.
    PubMed     Related articles   


  123. TRAN-JOHNSON TK , Sack DA, Marcus RN, Auby P, et al
    Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry. 2007;68:111-9.
    PubMed     Related articles    Abstract available


  124. NEWCOMER JW
    Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
    J Clin Psychiatry. 2007;68 Suppl 1:20-7.
    PubMed     Related articles    Abstract available


  125. NASRALLAH HA
    Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    J Clin Psychiatry. 2007;68 Suppl 1:3-4.
    PubMed     Related articles   


  126. YOUNG AH
    Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia.
    J Clin Psychiatry. 2007;68 Suppl 6:24-5.
    PubMed     Related articles    Abstract available


  127. GANGULI R
    Behavioral therapy for weight loss in patients with schizophrenia.
    J Clin Psychiatry. 2007;68 Suppl 4:19-25.
    PubMed     Related articles    Abstract available


  128. HENNEKENS CH
    Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia.
    J Clin Psychiatry. 2007;68 Suppl 4:4-7.
    PubMed     Related articles    Abstract available


  129. BUCKLEY PF
    Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
    J Clin Psychiatry. 2007;68 Suppl 6:5-9.
    PubMed     Related articles    Abstract available


  130. GOFF DC
    Integrating general health care in private community psychiatry practice.
    J Clin Psychiatry. 2007;68 Suppl 4:49-54.
    PubMed     Related articles    Abstract available


  131. PARKS JJ
    Implementing practice guidelines: lessons from public mental health settings.
    J Clin Psychiatry. 2007;68 Suppl 4:45-8.
    PubMed     Related articles    Abstract available


  132. WEIDEN PJ
    Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
    J Clin Psychiatry. 2007;68 Suppl 4:34-9.
    PubMed     Related articles    Abstract available


  133. SERNYAK MJ
    Implementation of monitoring and management guidelines for second-generation antipsychotics.
    J Clin Psychiatry. 2007;68 Suppl 4:14-8.
    PubMed     Related articles    Abstract available


  134. NEWCOMER JW
    Antipsychotic medications: metabolic and cardiovascular risk.
    J Clin Psychiatry. 2007;68 Suppl 4:8-13.
    PubMed     Related articles    Abstract available


  135. HENDERSON DC
    Weight gain with atypical antipsychotics: evidence and insights.
    J Clin Psychiatry. 2007;68 Suppl 12:18-26.
    PubMed     Related articles    Abstract available


  136. CITROME L
    The effectiveness criterion: balancing efficacy against the risks of weight gain.
    J Clin Psychiatry. 2007;68 Suppl 12:12-7.
    PubMed     Related articles    Abstract available


  137. CITROME L
    Introduction: weighing the evidence: weight management insights for treating major mental illness.
    J Clin Psychiatry. 2007;68 Suppl 12:4.
    PubMed     Related articles   


  138. BENCA RM
    Narcolepsy and excessive daytime sleepiness: diagnostic considerations, epidemiology, and comorbidities.
    J Clin Psychiatry. 2007;68 Suppl 13:5-8.
    PubMed     Related articles    Abstract available


  139. WEIDEN PJ
    Understanding and addressing adherence issues in schizophrenia: from theory to practice.
    J Clin Psychiatry. 2007;68 Suppl 14:14-9.
    PubMed     Related articles    Abstract available


  140. KEEFE RS
    Cognitive deficits in patients with schizophrenia: effects and treatment.
    J Clin Psychiatry. 2007;68 Suppl 14:8-13.
    PubMed     Related articles    Abstract available


  141. MCEVOY JP
    The costs of schizophrenia.
    J Clin Psychiatry. 2007;68 Suppl 14:4-7.
    PubMed     Related articles    Abstract available


  142. KANE JM
    Treatment strategies to prevent relapse and encourage remission.
    J Clin Psychiatry. 2007;68 Suppl 14:27-30.
    PubMed     Related articles    Abstract available


  143. MEYER JM
    Antipsychotic safety and efficacy concerns.
    J Clin Psychiatry. 2007;68 Suppl 14:20-6.
    PubMed     Related articles    Abstract available


    December 2006
  144. MARDER SR
    Schizophrenia: From Neuroimaging to Neuroscience.
    J Clin Psychiatry. 2006;67:2035.
    PubMed     Related articles    Abstract available


  145. MOELLER KE , Shireman TI, Liskow BI
    Relapse rates in patients with schizophrenia receiving aripiprazole in comparison with other atypical antipsychotics.
    J Clin Psychiatry. 2006;67:1942-7.
    PubMed     Related articles    Abstract available


  146. AKDEDE BB , Anil Yagcioglu AE, Alptekin K, Turgut TI, et al
    A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    J Clin Psychiatry. 2006;67:1912-9.
    PubMed     Related articles    Abstract available


  147. DE HERT M , Kalnicka D, van Winkel R, Wampers M, et al
    Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.
    J Clin Psychiatry. 2006;67:1889-96.
    PubMed     Related articles    Abstract available


  148. HERES S , Hamann J, Kissling W, Leucht S, et al
    Attitudes of psychiatrists toward antipsychotic depot medication.
    J Clin Psychiatry. 2006;67:1948-53.
    PubMed     Related articles    Abstract available


    November 2006
  149. NEWCOMER JW
    Medical risk in patients with bipolar disorder and schizophrenia.
    J Clin Psychiatry. 2006;67:e16.
    PubMed     Related articles    Abstract available


  150. KONDZIELLA D , Arlien-Soborg P
    Diagnostic and therapeutic challenges in narcolepsy-related psychosis.
    J Clin Psychiatry. 2006;67:1817-9.
    PubMed     Related articles   


  151. LEUCHT S , Kane JM
    Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia.
    J Clin Psychiatry. 2006;67:1813-4.
    PubMed     Related articles   


  152. EMSLEY R , Oosthuizen PP, Kidd M, Koen L, et al
    Remission in first-episode psychosis: predictor variables and symptom improvement patterns.
    J Clin Psychiatry. 2006;67:1707-12.
    PubMed     Related articles    Abstract available


  153. LAMBERT M , Schimmelmann BG, Naber D, Schacht A, et al
    Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.
    J Clin Psychiatry. 2006;67:1690-7.
    PubMed     Related articles    Abstract available


  154. WEIDEN PJ , Young AH, Buckley PF
    The art and science of switching of antipsychotic medications, part 1.
    J Clin Psychiatry. 2006;67:e15.
    PubMed     Related articles    Abstract available


    October 2006
  155. TAKAHASHI H , Kamata M, Yoshida K, Ishigooka J, et al
    Switching to Olanzapine After Unsuccessful Treatment With Risperidone During the First Episode of Schizophrenia: An Open-Label Trial.
    J Clin Psychiatry. 2006;67:1577-1582.
    PubMed     Related articles    Abstract available


  156. VALENSTEIN M , Ganoczy D, McCarthy JF, Myra Kim H, et al
    Antipsychotic Adherence Over Time Among Patients Receiving Treatment for Schizophrenia: A Retrospective Review.
    J Clin Psychiatry. 2006;67:1542-1550.
    PubMed     Related articles    Abstract available


  157. CRESPO-FACORRO B , Perez-Iglesias R, Ramirez-Bonilla M, Martinez-Garcia O, et al
    A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.
    J Clin Psychiatry. 2006;67:1511-1521.
    PubMed     Related articles    Abstract available


  158. VAN WINKEL R , De Hert M, Van Eyck D, Hanssens L, et al
    Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods.
    J Clin Psychiatry. 2006;67:1493-1500.
    PubMed     Related articles    Abstract available


  159. LIEBERMAN JA
    Neurobiology and the Natural History of Schizophrenia.
    J Clin Psychiatry. 2006;67:e14.
    PubMed     Related articles    Abstract available


  160. GREEN MF
    Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder.
    J Clin Psychiatry. 2006;67:e12.
    PubMed     Related articles    Abstract available


  161. LOPEZ-GARCIA P , Teresa Rodriguez J, De Castro P, Landecho I, et al
    Association between clozapine-induced agranulocytosis and HLA subtyping.
    J Clin Psychiatry. 2006;67:1652-3.
    PubMed     Related articles   


  162. BERNER MM , Hagen M, Kriston L
    A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
    J Clin Psychiatry. 2006;67:1649-50.
    PubMed     Related articles   


  163. HARVEY PD
    Cognitive and functional effects of atypical antipsychotic medications.
    J Clin Psychiatry. 2006;67:e13.
    PubMed     Related articles    Abstract available


    September 2006
  164. JUNG DU , Conley RR, Kelly DL, Kim DW, et al
    Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study.
    J Clin Psychiatry. 2006;67:1391-1396.
    PubMed     Related articles    Abstract available


  165. WEISSMAN EM , Zhu CW, Schooler NR, Goetz RR, et al
    Lipid Monitoring in Patients With Schizophrenia Prescribed Second-Generation Antipsychotics.
    J Clin Psychiatry. 2006;67:1323-1326.
    PubMed     Related articles    Abstract available


  166. TAMMINGA CA
    The Neurobiology of Cognition in Schizophrenia.
    J Clin Psychiatry. 2006;67:e11.
    PubMed     Related articles    Abstract available


  167. JARSKOG LF , Lieberman JA
    Neuroprotection in Schizophrenia.
    J Clin Psychiatry. 2006;67:e09.
    PubMed     Related articles    Abstract available


  168. GREEN AI , Brown ES
    Comorbid Schizophrenia and Substance Abuse.
    J Clin Psychiatry. 2006;67:e08.
    PubMed     Related articles    Abstract available


  169. MARKHAM-ABEDI C , de Leon J
    Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.
    J Clin Psychiatry. 2006;67:1473-4.
    PubMed     Related articles   


  170. MAGO R , Anolik R, Johnson RA, Kunkel EJ, et al
    Recurrent priapism associated with use of aripiprazole.
    J Clin Psychiatry. 2006;67:1471-2.
    PubMed     Related articles   


  171. LIN CY , Wu PL, Pariante CM, Su KP, et al
    A crossover study of prolactin changes associated with risperidone and olanzapine.
    J Clin Psychiatry. 2006;67:1470.
    PubMed     Related articles   


  172. KELLY DL , Dixon LB, Kreyenbuhl JA, Medoff D, et al
    Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.
    J Clin Psychiatry. 2006;67:1404-11.
    PubMed     Related articles    Abstract available


  173. PHILLIPS GA , Van Brunt DL, Roychowdhury SM, Xu W, et al
    The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.
    J Clin Psychiatry. 2006;67:1397-403.
    PubMed     Related articles    Abstract available


  174. TOPRAC MG , Dennehy EB, Carmody TJ, Crismon ML, et al
    Implementation of the Texas Medication Algorithm Project patient and family education program.
    J Clin Psychiatry. 2006;67:1362-72.
    PubMed     Related articles    Abstract available


    August 2006
  175. VINER MW , Matuszak JM, Knight LJ
    Initial dosing strategies for long-acting injectable risperidone.
    J Clin Psychiatry. 2006;67:1310-1.
    PubMed     Related articles   


  176. LIN SK , Chen CK
    Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
    J Clin Psychiatry. 2006;67:1307.
    PubMed     Related articles   


  177. MALASPINA D
    Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder.
    J Clin Psychiatry. 2006;67:e07.
    PubMed     Related articles    Abstract available


  178. HARVEY PD
    Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia.
    J Clin Psychiatry. 2006;67:e06.
    PubMed     Related articles    Abstract available


    July 2006
  179. MARDER SR
    Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness.
    J Clin Psychiatry. 2006;67:e03.
    PubMed     Related articles    Abstract available


    January 2006
  180. CAINE ED
    Clinical perspectives on atypical antipsychotics for treatment of agitation.
    J Clin Psychiatry. 2006;67 Suppl 10:22-31.
    PubMed     Related articles    Abstract available


  181. SACHS GS
    A review of agitation in mental illness: burden of illness and underlying pathology.
    J Clin Psychiatry. 2006;67 Suppl 10:5-12.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: